Company intelligence / Profile preview

Pure Asia Biotech Limited

Ownership: Private
Development stage: Commercial

Overview

The company has conducted functional tests including anti-SARS-CoV-2 activity, anti-cancer activity, and other health benefits, performed by their in-house science team and collaborators in Hong Kong and French academic institutes[2].

Therapeutic areas: OtherOncologyInfectious Diseases
Modalities: Plant proteins/peptides
Industry: Food & Nutrition

Drug pipeline

2 assets

Pure Health Immunity

Commercial

Indications: Immune support

1 more asset in the full pipeline.

Request access →

Partnerships

Collaborations with academic institutes in Hong Kong and France[2]

Beyond the preview

Go deeper on Pure Asia Biotech Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pure Asia Biotech Limited.

Explore the full profile